background
major
determin
retroviru
host
rang
presenc
absenc
appropri
cellsurfac
receptor
requir
viru
entri
often
ortholog
function
receptor
present
wide
rang
speci
amino
acid
differ
render
receptor
nonfunct
case
amino
acid
differ
result
addit
nlink
glycosyl
block
viru
infect
latter
block
retroviru
infect
overcom
treatment
cell
compound
tunicamycin
prevent
addit
nlink
oligosaccharid
discov
treatment
cell
liposom
compos
phosphatidylserin
ps
also
overcom
block
infect
mediat
nlink
glycosyl
importantli
effect
occur
without
appar
chang
glycosyl
state
receptor
virus
effect
occur
delay
kinet
compar
previou
result
show
enhanc
viru
infect
ps
treatment
cell
express
function
viru
receptor
demonstr
ps
treatment
reliev
block
retroviru
infect
cell
express
retrovir
receptor
render
nonfunct
glycosyl
find
import
implic
current
model
describ
inhibit
viru
entri
receptor
glycosyl
mani
cellular
receptor
retrovirus
well
character
review
see
receptor
perform
wide
varieti
cellular
function
singletransmembran
gpianchor
multiplemembranespan
protein
presenc
absenc
function
receptor
cell
surfac
major
determin
viru
tropism
case
otherwis
function
receptor
glycosyl
therefor
unus
particular
retrovirus
sinc
site
glycosyl
often
near
bind
site
use
virus
glycosyl
thought
import
defens
mechan
evolv
cell
battl
viru
infect
exampl
see
one
particularli
wellstudi
exampl
glycosylationblock
receptor
involv
cat
endogen
retroviru
unabl
enter
nih
mous
cell
unless
cell
treat
agent
includ
tunicamycin
prevent
addit
nlink
oligosaccharid
protein
endoplasm
reticulum
receptor
tunicamycintr
nih
cell
multiplemembran
span
protein
call
standard
name
neutral
amino
acid
transport
also
use
close
relat
human
protein
standard
name
also
call
rdr
receptor
sequenc
differ
mous
ortholog
human
prevent
serv
receptor
even
tunicamycin
treatment
exampl
glycosylationblock
receptor
hamster
rat
ortholog
receptor
moloney
murin
leukemia
viru
momlv
standard
name
prevent
receptor
glycosyl
treatment
rat
hamster
cell
tunicamycin
reliev
block
infect
momlv
like
amino
acid
transport
case
lysin
arginin
ornithin
nlink
glycosyl
site
mous
hamster
rat
remov
mutagenesi
protein
fulli
function
viru
receptor
date
remov
nlink
glycosyl
either
mutagenesi
oligosaccharid
attach
site
treatment
inhibitor
glycosyl
way
known
reliv
block
infect
momlv
virus
respect
rodent
cell
line
recent
shown
treatment
target
cell
phosphatidylserin
ps
enhanc
envelop
viru
infect
effect
observ
phospholipid
thought
occur
enhanc
viru
fusion
importantli
case
test
function
receptor
present
ps
treatment
enhanc
viru
infect
convers
function
receptor
present
ps
treatment
allow
infect
target
cell
show
phosphatidylserin
treatment
reliev
block
infect
mediat
glycosylationblock
receptor
investig
phenomenon
previou
work
demonstr
psdepend
enhanc
infect
requir
function
receptor
refer
effect
nonspecif
enhanc
viru
infect
ps
want
extend
observ
examin
effect
ps
viru
entri
case
receptor
present
inact
due
receptor
glycosyl
use
lapsn
retrovir
vector
encod
human
placent
alkalin
phosphatas
ap
marker
infect
virus
carri
vector
contain
gagpol
protein
momlv
env
protein
either
momlv
simplic
call
virus
momlv
vector
respect
momlv
vector
unabl
enter
cho
cell
vector
unabl
enter
nih
cell
unless
cell
first
treat
tunicamycin
prevent
receptor
glycosyl
tabl
show
pretreat
cho
nih
cell
ps
h
allow
effici
entri
momlv
vector
respect
hereaft
refer
effect
glycosylationspecif
enhanc
ps
contrast
nonspecif
enhanc
describ
previou
work
simpl
explan
result
might
ps
inhibit
receptor
glycosyl
tunicamycin
treatment
describ
murin
function
receptor
nih
cell
treat
tunicamycin
treatment
cell
lysat
peptid
nglycosidas
f
pngase
f
caus
increas
electrophoret
mobil
result
remov
nlink
glycosyl
attempt
examin
glycosyl
statu
myctag
protein
nih
cell
unabl
clearli
visual
protein
due
technic
problem
includ
high
background
antibodi
bind
howev
abl
examin
glycosyl
state
hemagglutinin
ha
tag
human
protein
nih
cell
figur
nonp
treat
cell
clear
increas
mobil
incub
pngase
f
demonstr
protein
normal
glycosyl
furthermor
none
protein
found
unglycosyl
state
prior
pngase
f
treatment
mobil
shift
observ
cell
treat
ps
indic
treatment
ps
affect
glycosyl
state
protein
nih
cell
examin
glycosyl
directli
transient
express
myctag
mous
cell
examin
effect
ps
treatment
glycosyl
figur
cell
treat
either
ps
left
untreat
concentr
ps
chosen
induc
highest
vector
infect
rate
cell
high
concentr
ps
toxic
cell
data
shown
hatag
protein
detect
unglycosyl
receptor
present
ps
treat
cell
indic
glycosyl
unaffect
ps
treatment
previous
postul
nonspecif
enhanc
viru
infect
ps
occur
effect
viru
fusion
true
effect
happen
rel
quickli
sinc
requir
ps
liposom
fuse
plasma
membran
cell
chang
physic
characterist
membran
undertook
infect
use
vector
normal
infect
nih
cell
given
short
exposur
ps
contrast
h
treatment
use
previou
experi
cell
treat
ps
h
viru
ad
h
cell
trypsin
replat
h
ps
treatment
viru
infect
increas
almost
experi
repeat
twice
result
much
full
increas
infect
treat
h
demonstr
effect
ps
viru
infect
inde
rapid
howev
parent
nih
cell
contain
glycosylationblock
receptor
treat
manner
infect
vector
observ
data
shown
preced
result
suggest
glycosylationspecif
enhanc
ps
treatment
delay
compar
nonspecif
enhanc
viru
infect
compar
two
effect
examin
vector
infect
nih
cell
nih
cell
longer
time
cours
cell
treat
ps
time
point
h
infect
vector
cell
surfac
ps
level
also
measur
timepoint
annexinv
stain
found
linear
relationship
time
ps
addit
amount
ps
present
outer
leaflet
membran
figur
top
panel
furthermor
direct
relationship
amount
ps
present
membran
infect
normallyinfect
nih
cell
vector
figur
middl
panel
contrast
long
delay
increas
vector
infect
nih
cell
follow
ps
addit
major
enhanc
viru
infect
occur
h
figur
bottom
panel
long
delay
addit
ps
glycosylationspecif
enhanc
viru
infect
suggest
analysi
nlink
oligosaccharid
modif
without
ps
treatment
figur
total
amount
ps
incorpor
plasma
membran
reduc
timepoint
satur
appear
reach
reduc
incorpor
ps
result
increas
delay
vector
infect
nih
cell
h
support
hypothesi
threshold
amount
ps
requir
glycosylationspecif
enhanc
viru
infect
appear
result
shown
figur
simpl
relationship
amount
ps
present
membran
nonspecif
enhanc
viru
infect
next
examin
effect
h
treatment
variou
concentr
ps
vector
infect
nih
cell
nih
cell
figur
infect
annexinv
measur
undertaken
previous
describ
low
level
report
ps
treatment
target
cell
contain
glycosylationblock
viral
receptor
allow
viru
infect
importantli
occur
without
remov
oligosaccharid
unlik
case
tunicamycin
treatment
furthermor
glycosylationspecif
effect
take
place
nih
cell
differ
timescal
nonspecif
enhanc
viru
infect
ps
appear
requir
threshold
concentr
cellsurfac
ps
nih
cell
treat
ps
reach
level
infect
h
treat
ps
take
longer
infect
observ
suggest
observ
enhanc
infect
mere
signal
cascad
initi
addit
ps
cell
one
explan
long
delay
de
novo
protein
synthesi
requir
glycosylationspecif
effect
ps
treatment
addit
experi
need
address
question
unfortun
preliminari
experi
demonstr
ps
treatment
combin
inhibit
protein
synthesi
cycloheximid
lethal
cell
data
shown
complic
analysi
addit
shown
nonspecif
enhanc
ps
occur
rapidli
direct
correl
amount
cellsurfac
ps
amount
nonspecif
enhanc
viru
infect
result
support
previou
hypothesi
nonspecif
enhanc
occur
influenc
viru
fusion
result
suggest
block
infect
glycosyl
receptor
may
occur
differ
stage
viru
entri
previous
assum
propos
glycosyl
prevent
momlv
bind
cognat
receptor
therebi
termin
viru
entri
earli
step
howev
result
demonstr
two
virus
still
infect
cell
contain
fulli
glycosyl
receptor
howev
rule
possibl
ps
might
induc
subtl
chang
receptor
glycosyl
alter
structur
branch
nlink
oligosaccharid
might
affect
viru
entri
instead
block
viru
bind
possibl
ps
affect
pack
mobil
receptor
plasma
membran
sever
group
suggest
receptor
cluster
multival
envreceptor
complex
requir
retroviru
infect
exampl
aslva
virion
appear
requir
multipl
contact
receptor
order
enter
fusogen
state
effect
ps
concentr
cellsurfac
ps
level
vector
infect
nih
nih
cell
nih
cell
possibl
glycosyl
receptor
normal
unabl
pack
tightli
move
membran
rapidli
unglycosyl
form
order
facilit
viru
infect
model
disrupt
plasma
membran
caus
ps
treatment
could
allow
suffici
concentr
receptor
contact
viral
env
protein
initi
fusion
exogen
ps
shown
affect
curvatur
stabil
lipid
bilay
provid
mechan
disrupt
hand
fewer
receptor
contact
could
requir
viru
form
fusion
pore
activ
energi
fusion
occur
lower
ps
treatment
similarli
possibl
glycosyl
receptor
prevent
membran
come
close
enough
contact
fuse
destabil
plasma
membran
ps
increas
distanc
fusion
occur
studi
requir
understand
mechan
glycosylationspecif
enhanc
viru
entri
ps
treatment
summari
result
expand
previou
find
regard
mechan
enhanc
viru
infect
ps
treatment
demonstr
effect
ps
treatment
cell
contain
glycosylationblock
receptor
abil
promot
nih
infect
momlv
vector
without
tunicamycin
treatment
interest
research
studi
virus
studi
natur
glycosylationinduc
block
retroviru
infect
cell
cultur
plasmid
nih
thymidin
kinasedefici
mous
embryo
fibroblast
human
embryon
kidney
cell
maintain
co
dulbecco
modifi
eagl
medium
high
concentr
glucos
g
per
liter
fb
hamster
cell
atcc
maintain
minim
essenti
medium
alpha
co
clonal
nih
cell
express
hatag
human
nih
cell
gener
transduct
retrovir
vector
lncrdrha
contain
human
rdr
cdna
carboxytermin
ha
tag
clone
lncx
retrovir
vector
express
plasmid
contain
myctag
murin
kindli
provid
david
kabat
lapsn
moloney
murin
leukemia
viru
momlv
base
vector
encod
human
placent
alkalin
phosphatas
ap
neomycin
phosphotransferas
lapsn
contain
virus
gener
follow
packag
line
express
indic
env
protein
flyrd
momlv
retrovir
vector
use
studi
harvest
medium
expos
produc
cell
centrifug
g
min
remov
cell
debri
retroviru
vector
infect
undertaken
follow
day
cell
plate
cellswel
dish
day
fresh
phospholipid
liposom
gener
ad
cell
unless
otherwis
note
day
medium
replac
fresh
medium
contain
polybren
viru
ad
well
day
cell
fix
glutaraldehyd
stain
ap
express
infect
time
cours
larg
batch
ps
liposom
produc
day
ad
cell
everi
h
h
h
cell
either
infect
describ
prepar
annexinv
label
alexa
fluor
annexinv
propidium
iodid
pi
annexin
bind
buffer
obtain
vybrant
apoptosi
assay
kit
molecular
probe
eugen
annexinv
label
perform
use
slight
variat
manufactur
protocol
previous
describ
geometr
mean
fluoresc
cell
obtain
unlabel
label
cell
popul
mean
unlabel
cell
subtract
mean
label
cell
determin
rel
amount
cellsurfac
ps
sampl
dead
cell
exclud
analysi
basi
pi
stain
obtain
mgml
solut
chloroform
methanol
sigma
st
loui
mo
gener
liposom
phospholipid
dri
glass
tube
nitrogen
resuspend
pb
final
concentr
mm
solut
sonic
ice
time
min
use
sonic
microtip
output
level
heat
system
ultrason
liposom
filter
pores
syring
filter
use
immedi
unless
otherwis
describ
analysi
hatag
human
wash
cell
lyse
min
lysi
buffer
mm
trishcl
ph
mm
nacl
centrifug
g
min
remov
nuclei
cell
debri
supernat
boil
min
addit
sd
final
concentr
respect
sampl
divid
equal
amount
either
pngase
f
new
